These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2345761)

  • 1. Suppression by ketamine and dextromethorphan of precipitated abstinence syndrome in rats.
    Koyuncuoğlu H; Güngör M; Sağduyu H; Aricioğlu F
    Pharmacol Biochem Behav; 1990 Apr; 35(4):829-32. PubMed ID: 2345761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tizanidine on morphine physical dependence: attenuation and intensification.
    Koyuncuŏglu H; Ariciŏglu F; Uresin Y; Dizdar Y; Esin Y
    Pharmacol Biochem Behav; 1992 Aug; 42(4):693-8. PubMed ID: 1355295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine.
    Koyuncuoğlu H; Saydam B
    Int J Clin Pharmacol Ther Toxicol; 1990 Apr; 28(4):147-52. PubMed ID: 2187002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Previous chronic blockade of NMDA receptors intensifies morphine dependence in rats.
    Koyuncuoğlu H; Aricioğlu F
    Pharmacol Biochem Behav; 1991 Jul; 39(3):575-9. PubMed ID: 1686099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of MK 801 on morphine physical dependence: attenuation and intensification.
    Koyuncuoğlu H; Dizdar Y; Aricioğlu F; Sayin U
    Pharmacol Biochem Behav; 1992 Oct; 43(2):487-90. PubMed ID: 1438485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of neonatal monosodium glutamate and aging on morphine dependence development.
    Koyuncuoğlu H; Aricioğlu F; Dizdar Y
    Pharmacol Biochem Behav; 1992 Oct; 43(2):341-5. PubMed ID: 1438475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensification and attenuation of morphine dependence by D-aspartic acid and PLG.
    Koyuncuoğlu H; Güngör M; Sağduyu H; Aricioğlu F
    Pharmacol Biochem Behav; 1990 Jan; 35(1):47-50. PubMed ID: 1969165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan attenuates morphine withdrawal syndrome in neonatal rats passively exposed to morphine.
    Yeh GC; Tao PL; Chen JY; Lai MC; Gao FS; Hu CL
    Eur J Pharmacol; 2002 Oct; 453(2-3):197-202. PubMed ID: 12398904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of different 4-aminopyridine and morphine combinations on the intensity of morphine abstinence.
    Koyuncuoğlu H; Nurten A; Enginar N; Ozerman B; Kara I
    Pharmacol Res; 2001 Mar; 43(3):245-50. PubMed ID: 11401416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mianserin attenuates naloxone-precipitated withdrawal signs in rats acutely or chronically dependent upon morphine.
    Neal BS; Sparber SB
    J Pharmacol Exp Ther; 1986 Jan; 236(1):157-65. PubMed ID: 3001281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single injection of three different preparations of alpha-interferon modifies morphine abstinence signs for a prolonged period.
    Dafny N; Reyes-Vazquez C
    Int J Neurosci; 1987 Feb; 32(3-4):953-61. PubMed ID: 3596938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.
    Taşkin T
    Psychopharmacology (Berl); 1986; 90(3):408-11. PubMed ID: 3097731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
    Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
    Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain asparaginase, ACE activity and plasma cortisol level in morphine dependent rats: effect of aspartic acid and naloxone.
    Koyuncuoğlu H; Güngör M; Enginar N; Hatipoğlu I; Hizal A
    Pharmacol Biochem Behav; 1986 Nov; 25(5):953-7. PubMed ID: 3024185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of harman and harmine on naloxone-precipitated withdrawal syndrome in morphine-dependent rats.
    Aricioglu-Kartal F; Kayir H; Tayfun Uzbay I
    Life Sci; 2003 Sep; 73(18):2363-71. PubMed ID: 12941438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking naloxone-precipitated withdrawal in rats and hamsters.
    Schnur P; Espinoza M; Flores R; Ortiz S; Vallejos S; Wainwright M
    Pharmacol Biochem Behav; 1992 Dec; 43(4):1093-8. PubMed ID: 1475293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists.
    González P; Cabello P; Germany A; Norris B; Contreras E
    Eur J Pharmacol; 1997 Aug; 332(3):257-62. PubMed ID: 9300257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ionotropic glutamatergic neurotransmission in the ventral tegmental area modulates DeltaFosB expression in the nucleus accumbens and abstinence syndrome in morphine withdrawal rats.
    Wang HL; Xiang XH; Guo Y; Wu WR; Cao DY; Wang HS; Zhao Y
    Eur J Pharmacol; 2005 Dec; 527(1-3):94-104. PubMed ID: 16303124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.